9 oct 2018
CPhI Worldwide 2018
Catalent

Catalent

Exhibitor at CPhI Worldwide 2018 stand 3D10, ICSE General Floor

About us

Catalyst + Talent

Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. With over 75 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing results.

We serve thousands of innovators, large and small, in over 100 markets, including 36 of the top 50 biotech companies and 49 of the top 50 pharmaceutical companies. Our team of over 1,000 talented scientists supports 40% of recent new drug approvals, and our nearly 30 global sites make or package over 100 billion units annually. Our significant intellectual property in oral, injectable, and respiratory dosage forms and advanced drug packaging includes over 1,200 patents and patent applications.

Specs about this supplier

Sales markets Asia; North America
Affiliated categories: API Contract Manufacturing |Bio Analytical Services |Biotechnology and related specialities More

Pharma Insight Briefings

Pharma & OTC: Entering the most prosperous emerging markets

11:50 - 12:20 ICSE Theatre

With the ever increasing global competition that Pharma & OTC companies are facing, more and more firms are turning to the Emerging Markets where growth rates are significantly higher than those in the mature markets. The growth potential of these regions offer attractive internationalization opportunities for foreign Pharma & OTC companies. Countries in Asia, Middle East, Latin America and the CIS region are particularly interesting for foreign Pharma & OTC companies looking to geographically expand. One example is Mexico, which has the second largest pharmaceutical market in Latin America. Internationalizing into the Emerging Markets is not a straight forward process. With the example of Mexico, the registration process can be lengthy and complex. We find that applying a systematic approach to internationalization improves the efficiency and success rate of the process.Throughout this session, the opportunities for Pharma & OTC companies in the Emerging Markets will be discussed and strategies for approaching new markets will be explained. Additionally, a case study will be presented on the Mexican cough & cold market.

More Information

Products featured at CPhI Worldwide 2018

View all our products (19)
Catalent

Event information

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain Visit us at stand 3D10